Medicamen Biotech Limited — Board Meeting, 25-04-2025: Outcome of Board Meeting

The Board of Directors of Medicamen Biotech Limited has approved the allotment of 8,48,215 equity shares at an issue price of ₹530 each, raising approximately ₹44.96 Cr from non-promoters. Additionally, they will issue up to 6,50,000 fully convertible warrants at the same price, expected to generate about ₹34.45 Cr from both promoter and non-promoter categories. Following this allotment, the company's paid-up equity share capital increases to ₹13.56 Cr. This strategic move aims to bolster the company's financial standing and support future initiatives.